Colorectal Cancer Clinical Trial Patient Recruitment

Colorectal cancer patient recruitment for clinical trials targeting MSI-H, KRAS, BRAF, and other molecular subtypes.

Who qualifies: Adults with Stage II–IV colorectal cancer, including MSI-H/dMMR and RAS/RAF wild-type patients.

Recruitment challenges: Molecular subtype eligibility and prior chemotherapy requirements create narrow enrollment windows.

Our approach: GI oncology referral networks, patient advocacy partnerships, and biomarker-guided pre-screening protocols.